Transforming Research and Clinical Knowledge in Geriatric Traumatic Brain Injury (TRACK-GERI) (TRACK-GERI)

December 18, 2025 updated by: University of California, San Francisco
The purpose of this study is to improve the diagnosis and prediction of recovery after traumatic brain injury (TBI) in adults age 65 years and older. The study will follow older adults who present to the emergency department after TBI, as well as matched control participants, and will measure clinical features, brain imaging, and blood-based biomarkers over 12 months to understand how recovery changes over time. Researchers will examine how pre-injury health, brain structure, and biological markers are related to disability and cognitive outcomes after TBI. Information from this study will be used to develop age-appropriate tools to better diagnose TBI and estimate long-term outcomes in older adults.

Study Overview

Status

Enrolling by invitation

Study Type

Observational

Enrollment (Estimated)

1500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Francisco, California, United States, 94110
        • University of California, San Francisco
      • San Francisco, California, United States, 94121
        • San Francisco Veterans Affairs Medical Center
    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15213
        • University of Pittsburgh

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Participants are those with and without TBI, along with study partners.

Description

TRACK-GERI/VA TBI PATIENT INCLUSION/EXCLUSION CRITERIA

Inclusion Criteria:

  1. Age 65 years and older, no upper age limit
  2. Reliable report or physical evidence of head trauma
  3. Injury occurred <72 hours ago (within 14 days of injury for TRACK-VA TBI patients)
  4. Acute brain CT for clinical use
  5. Fluency in English/Chinese (UCSF only)
  6. Ability to obtain informed consent from subject or legally authorized representative
  7. Ability to be co-enrolled with a study partner who meets Study Partner enrollment criteria

Exclusion Criteria:

  1. Significant polytrauma that would interfere with follow-up and outcome assessment
  2. Prisoners or patients in custody
  3. Patients on psychiatric hold (e.g. 5150, 5250)
  4. Low likelihood follow-up (participant or family is indicating a low interest, homelessness, out of state/country)
  5. Current participation in an interventional trial
  6. Penetrating TBI
  7. Spinal cord injury with ASIA score of C or worse
  8. Acute disabling neurological injury (e.g. acute stroke, cardiac arrest concurrent with head trauma presentation)

TRACK-GERI/VA STUDY PARTNERS OF TBI PATIENTS INCLUSION/EXCLUSION CRITERIA

Inclusion Criteria:

  1. Age 18 years or older
  2. Either designated by the patient, presents with patient to the Emergency Department, is listed in the patient's medical chart as an alternate/emergency contact, or is the patient's case manager/social worker, and knows the patient well enough to comment on the patient's health and functional status (e.g. may be family member, friend, caregiver, case manager, etc).
  3. Ability to read, write, and speak English/Chinese (UCSF only)
  4. Ability to provide informed consent for self

Exclusion Criteria:

  1. Pre-existing and major disabling medical, psychiatric, or other neurological disease (e.g. dementia) that interferes with ability to provide evaluation of patient's health and functional status.
  2. Prisoners or patients in custody
  3. Patients on psychiatric hold (e.g. 5150, 5250)

TRACK-GERI/VA CONTROL SUBJECT INCLUSION/EXCLUSION CRITERIA

Inclusion Criteria:

  1. Age 65 years or older, no upper age limit
  2. Visual acuity/hearing adequate for testing
  3. Fluency in English/Chinese (UCSF only)
  4. Ability to obtain informed consent from subject or legally authorized representative
  5. Ability to be co-enrolled with a study partner who meets study partner enrollment criteria (see control study partner enrollment criteria)
  6. For TRACK-VA patients only: Presentation to SFVAMC ED for acute care with planned discharge from ED.

Exclusion Criteria:

  1. Medically diagnosed with traumatic brain or orthopedic injury in the last year (TRACK-VA Control Subjects are not excluded for orthopedic injuries)
  2. Significant polytrauma that would interfere with follow-up and outcome assessment
  3. Prisoners or patients in custody
  4. Patients on psychiatric hold (e.g. 5150, 5250)
  5. Low likelihood follow-up (participant or family is indicating low interest, homelessness, out of state/country)
  6. Current participation in an interventional trial
  7. Penetrating TBI
  8. Spinal cord injury with ASIA score of C or worse
  9. Acute disabling neurological injury (e.g. acute stroke, cardiac arrest)

TRACK-GERI/VA STUDY PARTNERS OF CONTROL SUBJECTS INCLUSION/EXCLUSION CRITERIA

Inclusion Criteria:

  1. Age 18 years or older
  2. Designated by the control subject as someone who knows the subject well enough to comment on their health and functional starus (e.g., may be family member, friend, caregiver, case manager, etc.)
  3. Ability to read, write and speak English/Chinese (UCSF only)
  4. Ability to provide informed consent for self

Exclusion Criteria:

  1. Pre-existing and major disabling medical, psychiatric, or other neurological disease (e.g. dementia) that interferes with ability to provide evaluation of control subject's health and functional status.
  2. Prisoners or in custody
  3. On psychiatric hold (e.g. 5150, 5250)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
TRACK-GERI TBI Patients
TBI patients
TRACK-GERI Study Partners of TBI Patients
Study partners of TBI patients
TRACK-GERI Controls
Controls
TRQACK-GERI Study Partners of Control Patients
Study partners of control patients
TRACK-VA TBI Patients
VA TBI patients
TRACK-VA Study Partners of TBI Patients
Study partners of VA TBI patients
TRACK-VA Controls
VA controls
TRACK-VA Study Partners of Control Patients
Study partners of VA control patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Outcome at 6 Months Post-Injury as Assessed by the Glasgow Outcome Scale-Extended (GOSE)
Time Frame: 6 months post-injury
Functional outcome after traumatic brain injury will be measured using the Glasgow Outcome Scale-Extended (GOSE). The score ranges from 1-8, with higher scores indicating better recovery. The primary outcome is GOSE assessed at 6 months post-injury.
6 months post-injury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 2, 2019

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Study Registration Dates

First Submitted

December 16, 2025

First Submitted That Met QC Criteria

December 18, 2025

First Posted (Actual)

December 22, 2025

Study Record Updates

Last Update Posted (Actual)

December 22, 2025

Last Update Submitted That Met QC Criteria

December 18, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • TRACK-GERI
  • 1R01NS110944 (U.S. NIH Grant/Contract)
  • K23NS095755 (U.S. NIH Grant/Contract)
  • 1K76AG083285 (U.S. NIH Grant/Contract)
  • W81XWH2110469 (Other Grant/Funding Number: United States Department of Defense)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data will be made available through the Federal Interagency TBI Research (FITBIR) Database.

IPD Sharing Time Frame

Shared scientific data will be made accessible as soon as possible, and no later than the time of an associated publication, or the end of performance period, whichever comes first.

IPD Sharing Access Criteria

FITBIR qualified investigators will be provided access.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Traumatic Brain Injury

3
Subscribe